Global and United States Contraceptives Market Insights, Forecast to 2027

Publisher Name :
Date: 10-Sep-2021
No. of pages: 148
Inquire Before Buying

Contraceptives are a kind of medicine used to prevent unwanted pregnancy. It consists of one or more synthetic female sex hormones. These sex hormones prevent pregnancy by blocking the normal process of ovulation.

Europe is the largest Contraceptives market with about 44% market share. North America is follower, accounting for about 37% market share.

The key players are Bayer AG, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, Merck & Co., Inc, Actavis, Inc., Johnson & Johnson, Gedeon Richter, Novo Nordisk A/S, ZiZhu, Baijingyu, Huazhong, Sine etc. Top 3 companies occupied about 46% market share.

Market Analysis and Insights: Global and United States Contraceptives Market

This report focuses on global and United States Contraceptives market.

In 2020, the global Contraceptives market size was US$ 1868.5 million and it is expected to reach US$ 2217.2 million by the end of 2027, with a CAGR of 2.5% during 2021-2027. In United States the Contraceptives market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Contraceptives Scope and Market Size

Contraceptives market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Contraceptives market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For United States market, this report focuses on the Contraceptives market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in United States.

Segment by Type

- Prolonged Contraception

- Short-term Contraception

- Emergency Contraception

Segment by Application

- Hospital Pharmacies

- Retail Pharmacies

- Online Pharmacies

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- Bayer AG

- Pfizer, Inc

- Teva Pharmaceutical Industries Ltd

- Merck & Co., Inc

- Actavis, Inc.

- Johnson & Johnson

- Gedeon Richter

- Novo Nordisk A/S

- ZiZhu

- Baijingyu

- Huazhong

- Sine

Global and United States Contraceptives Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Contraceptives Product Introduction
1.2 Market by Type
1.2.1 Global Contraceptives Market Size Growth Rate by Type
1.2.2 Prolonged Contraception
1.2.3 Short-term Contraception
1.2.4 Emergency Contraception
1.3 Market by Application
1.3.1 Global Contraceptives Market Size Growth Rate by Application
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Contraceptives Market Size, Estimates and Forecasts
2.1.1 Global Contraceptives Revenue 2016-2027
2.1.2 Global Contraceptives Sales 2016-2027
2.2 Global Contraceptives, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Contraceptives Historical Market Size by Region (2016-2021)
2.3.1 Global Contraceptives Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Contraceptives Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Contraceptives Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Contraceptives Sales Forecast by Region (2022-2027)
2.4.2 Global Contraceptives Revenue Forecast by Region (2022-2027)
3 Global Contraceptives Competitor Landscape by Players
3.1 Global Top Contraceptives Manufacturers by Sales
3.1.1 Global Contraceptives Sales by Manufacturer (2016-2021)
3.1.2 Global Contraceptives Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Contraceptives Manufacturers by Revenue
3.2.1 Key Contraceptives Manufacturers Covered: Ranking by Revenue
3.2.2 Global Contraceptives Revenue by Manufacturers (2016-2021)
3.2.3 Global Contraceptives Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Contraceptives Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Contraceptives Revenue in 2020
3.2.6 Global Contraceptives Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Contraceptives Price by Manufacturers
3.4 Global Contraceptives Manufacturing Base Distribution, Product Types
3.4.1 Contraceptives Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Contraceptives Product Type
3.4.3 Date of International Manufacturers Enter into Contraceptives Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Contraceptives Market Size by Type (2016-2021)
4.1.1 Global Contraceptives Sales by Type (2016-2021)
4.1.2 Global Contraceptives Revenue by Type (2016-2021)
4.1.3 Contraceptives Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Contraceptives Market Size Forecast by Type (2022-2027)
4.2.1 Global Contraceptives Sales Forecast by Type (2022-2027)
4.2.2 Global Contraceptives Revenue Forecast by Type (2022-2027)
4.2.3 Contraceptives Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Contraceptives Market Size by Application (2016-2021)
5.1.1 Global Contraceptives Sales by Application (2016-2021)
5.1.2 Global Contraceptives Revenue by Application (2016-2021)
5.1.3 Contraceptives Price by Application (2016-2021)
5.2 Contraceptives Market Size Forecast by Application (2022-2027)
5.2.1 Global Contraceptives Sales Forecast by Application (2022-2027)
5.2.2 Global Contraceptives Revenue Forecast by Application (2022-2027)
5.2.3 Global Contraceptives Price Forecast by Application (2022-2027)
6 United States by Players, Type and Application
6.1 United States Contraceptives Market Size YoY Growth 2016-2027
6.1.1 United States Contraceptives Sales YoY Growth 2016-2027
6.1.2 United States Contraceptives Revenue YoY Growth 2016-2027
6.1.3 United States Contraceptives Market Share in Global Market 2016-2027
6.2 United States Contraceptives Market Size by Players (International and Local Players)
6.2.1 United States Top Contraceptives Players by Sales (2016-2021)
6.2.2 United States Top Contraceptives Players by Revenue (2016-2021)
6.3 United States Contraceptives Historic Market Review by Type (2016-2021)
6.3.1 United States Contraceptives Sales Market Share by Type (2016-2021)
6.3.2 United States Contraceptives Revenue Market Share by Type (2016-2021)
6.3.3 United States Contraceptives Price by Type (2016-2021)
6.4 United States Contraceptives Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Contraceptives Sales Forecast by Type (2022-2027)
6.4.2 United States Contraceptives Revenue Forecast by Type (2022-2027)
6.4.3 United States Contraceptives Price Forecast by Type (2022-2027)
6.5 United States Contraceptives Historic Market Review by Application (2016-2021)
6.5.1 United States Contraceptives Sales Market Share by Application (2016-2021)
6.5.2 United States Contraceptives Revenue Market Share by Application (2016-2021)
6.5.3 United States Contraceptives Price by Application (2016-2021)
6.6 United States Contraceptives Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Contraceptives Sales Forecast by Application (2022-2027)
6.6.2 United States Contraceptives Revenue Forecast by Application (2022-2027)
6.6.3 United States Contraceptives Price Forecast by Application (2022-2027)
7 North America
7.1 North America Contraceptives Market Size YoY Growth 2016-2027
7.2 North America Contraceptives Market Facts & Figures by Country
7.2.1 North America Contraceptives Sales by Country (2016-2021)
7.2.2 North America Contraceptives Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Contraceptives Market Size YoY Growth 2016-2027
8.2 Asia Pacific Contraceptives Market Facts & Figures by Region
8.2.1 Asia Pacific Contraceptives Sales by Region (2016-2021)
8.2.2 Asia Pacific Contraceptives Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Contraceptives Market Size YoY Growth 2016-2027
9.2 Europe Contraceptives Market Facts & Figures by Country
9.2.1 Europe Contraceptives Sales by Country (2016-2021)
9.2.2 Europe Contraceptives Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Contraceptives Market Size YoY Growth 2016-2027
10.2 Latin America Contraceptives Market Facts & Figures by Country
10.2.1 Latin America Contraceptives Sales by Country (2016-2021)
10.2.2 Latin America Contraceptives Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Contraceptives Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Contraceptives Market Facts & Figures by Country
11.2.1 Middle East and Africa Contraceptives Sales by Country (2016-2021)
11.2.2 Middle East and Africa Contraceptives Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Bayer AG
12.1.1 Bayer AG Corporation Information
12.1.2 Bayer AG Description and Business Overview
12.1.3 Bayer AG Contraceptives Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Bayer AG Contraceptives Products Offered
12.1.5 Bayer AG Recent Development
12.2 Pfizer, Inc
12.2.1 Pfizer, Inc Corporation Information
12.2.2 Pfizer, Inc Description and Business Overview
12.2.3 Pfizer, Inc Contraceptives Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Pfizer, Inc Contraceptives Products Offered
12.2.5 Pfizer, Inc Recent Development
12.3 Teva Pharmaceutical Industries Ltd
12.3.1 Teva Pharmaceutical Industries Ltd Corporation Information
12.3.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
12.3.3 Teva Pharmaceutical Industries Ltd Contraceptives Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Teva Pharmaceutical Industries Ltd Contraceptives Products Offered
12.3.5 Teva Pharmaceutical Industries Ltd Recent Development
12.4 Merck & Co., Inc
12.4.1 Merck & Co., Inc Corporation Information
12.4.2 Merck & Co., Inc Description and Business Overview
12.4.3 Merck & Co., Inc Contraceptives Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Merck & Co., Inc Contraceptives Products Offered
12.4.5 Merck & Co., Inc Recent Development
12.5 Actavis, Inc.
12.5.1 Actavis, Inc. Corporation Information
12.5.2 Actavis, Inc. Description and Business Overview
12.5.3 Actavis, Inc. Contraceptives Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Actavis, Inc. Contraceptives Products Offered
12.5.5 Actavis, Inc. Recent Development
12.6 Johnson & Johnson
12.6.1 Johnson & Johnson Corporation Information
12.6.2 Johnson & Johnson Description and Business Overview
12.6.3 Johnson & Johnson Contraceptives Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Johnson & Johnson Contraceptives Products Offered
12.6.5 Johnson & Johnson Recent Development
12.7 Gedeon Richter
12.7.1 Gedeon Richter Corporation Information
12.7.2 Gedeon Richter Description and Business Overview
12.7.3 Gedeon Richter Contraceptives Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Gedeon Richter Contraceptives Products Offered
12.7.5 Gedeon Richter Recent Development
12.8 Novo Nordisk A/S
12.8.1 Novo Nordisk A/S Corporation Information
12.8.2 Novo Nordisk A/S Description and Business Overview
12.8.3 Novo Nordisk A/S Contraceptives Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Novo Nordisk A/S Contraceptives Products Offered
12.8.5 Novo Nordisk A/S Recent Development
12.9 ZiZhu
12.9.1 ZiZhu Corporation Information
12.9.2 ZiZhu Description and Business Overview
12.9.3 ZiZhu Contraceptives Sales, Revenue and Gross Margin (2016-2021)
12.9.4 ZiZhu Contraceptives Products Offered
12.9.5 ZiZhu Recent Development
12.10 Baijingyu
12.10.1 Baijingyu Corporation Information
12.10.2 Baijingyu Description and Business Overview
12.10.3 Baijingyu Contraceptives Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Baijingyu Contraceptives Products Offered
12.10.5 Baijingyu Recent Development
12.11 Bayer AG
12.11.1 Bayer AG Corporation Information
12.11.2 Bayer AG Description and Business Overview
12.11.3 Bayer AG Contraceptives Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Bayer AG Contraceptives Products Offered
12.11.5 Bayer AG Recent Development
12.12 Sine
12.12.1 Sine Corporation Information
12.12.2 Sine Description and Business Overview
12.12.3 Sine Contraceptives Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Sine Products Offered
12.12.5 Sine Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Contraceptives Industry Trends
13.2 Contraceptives Market Drivers
13.3 Contraceptives Market Challenges
13.4 Contraceptives Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Contraceptives Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Contraceptives Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Prolonged Contraception
Table 3. Major Manufacturers of Short-term Contraception
Table 4. Major Manufacturers of Emergency Contraception
Table 5. Global Contraceptives Market Size Growth Rate by Application (2021-2027) & (MT)
Table 6. Global Contraceptives Market Size by Region (MT) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global Contraceptives Sales by Regions (2016-2021) & (MT)
Table 8. Global Contraceptives Sales Market Share by Regions (2016-2021)
Table 9. Global Contraceptives Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global Contraceptives Sales Forecast by Region (2022-2027) & (MT)
Table 11. Global Contraceptives Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Contraceptives Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Contraceptives Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global Contraceptives Sales by Manufacturers (2016-2021) (MT)
Table 15. Global Contraceptives Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top Contraceptives Manufacturers by Revenue (US$ Million) in 2020
Table 17. Contraceptives Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. Contraceptives Revenue Share by Manufacturers (2016-2021)
Table 19. Global Contraceptives Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Contraceptives by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Contraceptives as of 2020)
Table 21. Key Manufacturers Contraceptives Price (2016-2021) (USD/Kg)
Table 22. Contraceptives Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Contraceptives Product Type
Table 24. Date of International Manufacturers Enter into Contraceptives Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Contraceptives Sales by Type (2016-2021) (MT)
Table 27. Global Contraceptives Sales Share by Type (2016-2021)
Table 28. Global Contraceptives Revenue by Type (2016-2021) (US$ Million)
Table 29. Global Contraceptives Revenue Share by Type (2016-2021)
Table 30. Contraceptives Average Selling Price (ASP) by Type (2016-2021) & (USD/Kg)
Table 31. Global Contraceptives Sales Forecast by Type (2022-2027) & (MT)
Table 32. Global Contraceptives Sales Market Share Forecast by Type (2022-2027)
Table 33. Global Contraceptives Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global Contraceptives Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global Contraceptives Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Kg)
Table 36. Global Contraceptives Sales by Application (2016-2021) (MT)
Table 37. Global Contraceptives Sales Share by Application (2016-2021)
Table 38. Global Contraceptives Revenue by Application (2016-2021) (US$ Million)
Table 39. Global Contraceptives Revenue Share by Application (2016-2021)
Table 40. Contraceptives Average Selling Price (ASP) by Application (2016-2021) & (USD/Kg)
Table 41. Global Contraceptives Sales Forecast by Application (2022-2027) & (MT)
Table 42. Global Contraceptives Sales Market Share Forecast by Application (2022-2027)
Table 43. Global Contraceptives Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global Contraceptives Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global Contraceptives Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Kg)
Table 46. United States Contraceptives Sales (MT) of Key Companies (2016-2021)
Table 47. United States Contraceptives Sales Share by Company (2016-2021)
Table 48. United States Contraceptives Revenue (US$ Million) by Company (2016-2021)
Table 49. United States Contraceptives Revenue Share by Company (2016-2021)
Table 50. United States Contraceptives Sales (MT) by Type (2016-2021)
Table 51. United States Contraceptives Sales Share by Type (2016-2021)
Table 52. United States Contraceptives Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. United States Contraceptives Price (USD/Kg) by Type (2016-2021)
Table 54. United States Contraceptives Sales (MT) by Type (2022-2027)
Table 55. United States Contraceptives Sales Share by Type (2022-2027)
Table 56. United States Contraceptives Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. United States Contraceptives Revenue Share by Type (2022-2027)
Table 58. United States Contraceptives Price (USD/Kg) by Type (2022-2027)
Table 59. United States Contraceptives Sales (MT) by Application (2016-2021)
Table 60. United States Contraceptives Sales Share by Application (2016-2021)
Table 61. United States Contraceptives Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. United States Contraceptives Price (USD/Kg) by Application (2016-2021)
Table 63. United States Contraceptives Sales (MT) by Application (2022-2027)
Table 64. United States Contraceptives Sales Share by Application (2022-2027)
Table 65. United States Contraceptives Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. United States Contraceptives Revenue Share by Application (2022-2027)
Table 67. United States Contraceptives Price (USD/Kg) by Application (2022-2027)
Table 68. North America Contraceptives Sales by Country (2016-2021) & (MT)
Table 69. North America Contraceptives Sales Market Share by Country (2016-2021)
Table 70. North America Contraceptives Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America Contraceptives Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific Contraceptives Sales by Region (2016-2021) & (MT)
Table 73. Asia Pacific Contraceptives Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific Contraceptives Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific Contraceptives Revenue Market Share by Region (2016-2021)
Table 76. Europe Contraceptives Sales by Country (2016-2021) & (MT)
Table 77. Europe Contraceptives Sales Market Share by Country (2016-2021)
Table 78. Europe Contraceptives Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe Contraceptives Revenue Market Share by Country (2016-2021)
Table 80. Latin America Contraceptives Sales by Country (2016-2021) & (MT)
Table 81. Latin America Contraceptives Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa Contraceptives Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America Contraceptives Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa Contraceptives Sales by Country (2016-2021) & (MT)
Table 85. Middle East and Africa Contraceptives Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa Contraceptives Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa Contraceptives Revenue Market Share by Country (2016-2021)
Table 88. Bayer AG Corporation Information
Table 89. Bayer AG Description and Business Overview
Table 90. Bayer AG Contraceptives Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 91. Bayer AG Contraceptives Product
Table 92. Bayer AG Recent Development
Table 93. Pfizer, Inc Corporation Information
Table 94. Pfizer, Inc Description and Business Overview
Table 95. Pfizer, Inc Contraceptives Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 96. Pfizer, Inc Product
Table 97. Pfizer, Inc Recent Development
Table 98. Teva Pharmaceutical Industries Ltd Corporation Information
Table 99. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 100. Teva Pharmaceutical Industries Ltd Contraceptives Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 101. Teva Pharmaceutical Industries Ltd Product
Table 102. Teva Pharmaceutical Industries Ltd Recent Development
Table 103. Merck & Co., Inc Corporation Information
Table 104. Merck & Co., Inc Description and Business Overview
Table 105. Merck & Co., Inc Contraceptives Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 106. Merck & Co., Inc Product
Table 107. Merck & Co., Inc Recent Development
Table 108. Actavis, Inc. Corporation Information
Table 109. Actavis, Inc. Description and Business Overview
Table 110. Actavis, Inc. Contraceptives Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 111. Actavis, Inc. Product
Table 112. Actavis, Inc. Recent Development
Table 113. Johnson & Johnson Corporation Information
Table 114. Johnson & Johnson Description and Business Overview
Table 115. Johnson & Johnson Contraceptives Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 116. Johnson & Johnson Product
Table 117. Johnson & Johnson Recent Development
Table 118. Gedeon Richter Corporation Information
Table 119. Gedeon Richter Description and Business Overview
Table 120. Gedeon Richter Contraceptives Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 121. Gedeon Richter Product
Table 122. Gedeon Richter Recent Development
Table 123. Novo Nordisk A/S Corporation Information
Table 124. Novo Nordisk A/S Description and Business Overview
Table 125. Novo Nordisk A/S Contraceptives Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 126. Novo Nordisk A/S Product
Table 127. Novo Nordisk A/S Recent Development
Table 128. ZiZhu Corporation Information
Table 129. ZiZhu Description and Business Overview
Table 130. ZiZhu Contraceptives Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 131. ZiZhu Product
Table 132. ZiZhu Recent Development
Table 133. Baijingyu Corporation Information
Table 134. Baijingyu Description and Business Overview
Table 135. Baijingyu Contraceptives Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 136. Baijingyu Product
Table 137. Baijingyu Recent Development
Table 138. Huazhong Corporation Information
Table 139. Huazhong Description and Business Overview
Table 140. Huazhong Contraceptives Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 141. Huazhong Product
Table 142. Huazhong Recent Development
Table 143. Sine Corporation Information
Table 144. Sine Description and Business Overview
Table 145. Sine Contraceptives Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 146. Sine Product
Table 147. Sine Recent Development
Table 148. Contraceptives Market Trends
Table 149. Contraceptives Market Drivers
Table 150. Contraceptives Market Challenges
Table 151. Contraceptives Market Restraints
Table 152. Contraceptives Customers List
Table 153. Contraceptives Distributors List
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Contraceptives Product Picture
Figure 2. Global Contraceptives Sales Market Share by Type in 2020 & 2027
Figure 3. Prolonged Contraception Product Picture
Figure 4. Short-term Contraception Product Picture
Figure 5. Emergency Contraception Product Picture
Figure 6. Global Contraceptives Sales Market Share by Application in 2020 & 2027
Figure 7. Hospital Pharmacies
Figure 8. Retail Pharmacies
Figure 9. Online Pharmacies
Figure 10. Others
Figure 11. Contraceptives Report Years Considered
Figure 12. Global Contraceptives Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Contraceptives Market Size 2016-2027 (US$ Million)
Figure 14. Global Contraceptives Sales 2016-2027 (MT)
Figure 15. Global Contraceptives Market Size Market Share by Region: 2021 Versus 2027
Figure 16. Global Contraceptives Sales Market Share by Region (2016-2021)
Figure 17. Global Contraceptives Sales Market Share by Region in 2020
Figure 18. Global Contraceptives Revenue Market Share by Region (2016-2021)
Figure 19. Global Contraceptives Revenue Market Share by Region in 2020
Figure 20. Global Contraceptives Sales Share by Manufacturer in 2020
Figure 21. The Top 10 and 5 Players Market Share by Contraceptives Revenue in 2020
Figure 22. Contraceptives Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 23. Global Contraceptives Sales Market Share by Type (2016-2021)
Figure 24. Global Contraceptives Sales Market Share by Type in 2020
Figure 25. Global Contraceptives Revenue Market Share by Type (2016-2021)
Figure 26. Global Contraceptives Revenue Market Share by Type in 2020
Figure 27. Global Contraceptives Sales Market Share by Application (2016-2021)
Figure 28. Global Contraceptives Sales Market Share by Application in 2020
Figure 29. Global Contraceptives Revenue Market Share by Application (2016-2021)
Figure 30. Global Contraceptives Revenue Market Share by Application in 2020
Figure 31. United States Contraceptives Sales Growth Rate 2016-2027 (MT)
Figure 32. United States Contraceptives Revenue Growth Rate 2016-2027 (US$ Million)
Figure 33. United States Contraceptives Market Share in Global Market 2016-2027
Figure 34. United States 5 and 10 Largest Contraceptives Players Market Share by Revenue in Contraceptives in 2020
Figure 35. United States Contraceptives Revenue Share by Type (2016-2021)
Figure 36. United States Contraceptives Revenue Growth Rate by Type in 2016 & 2020
Figure 37. United States Contraceptives Revenue Share by Application (2016-2021)
Figure 38. United States Contraceptives Revenue Growth Rate by Application in 2016 & 2020
Figure 39. North America Contraceptives Sales Growth Rate 2016-2021 (MT)
Figure 40. North America Contraceptives Revenue Growth Rate 2016-2021 (US$ Million)
Figure 41. North America Contraceptives Sales Market Share by Country in 2020
Figure 42. North America Contraceptives Revenue Market Share by Country in 2020
Figure 43. U.S. Contraceptives Sales Growth Rate (2016-2021) (MT)
Figure 44. U.S. Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Canada Contraceptives Sales Growth Rate (2016-2021) (MT)
Figure 46. Canada Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Europe Contraceptives Sales Growth Rate 2016-2021 (MT)
Figure 48. Europe Contraceptives Revenue Growth Rate 2016-2021 (US$ Million)
Figure 49. Europe Contraceptives Sales Market Share by Country in 2020
Figure 50. Europe Contraceptives Revenue Market Share by Country in 2020
Figure 51. Germany Contraceptives Sales Growth Rate (2016-2021) (MT)
Figure 52. Germany Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. France Contraceptives Sales Growth Rate (2016-2021) (MT)
Figure 54. France Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. U.K. Contraceptives Sales Growth Rate (2016-2021) (MT)
Figure 56. U.K. Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Italy Contraceptives Sales Growth Rate (2016-2021) (MT)
Figure 58. Italy Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Russia Contraceptives Sales Growth Rate (2016-2021) (MT)
Figure 60. Russia Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Asia Pacific Contraceptives Sales Growth Rate 2016-2021 (MT)
Figure 62. Asia Pacific Contraceptives Revenue Growth Rate 2016-2021 (US$ Million)
Figure 63. Asia Pacific Contraceptives Sales Market Share by Region in 2020
Figure 64. Asia Pacific Contraceptives Revenue Market Share by Region in 2020
Figure 65. China Contraceptives Sales Growth Rate (2016-2021) (MT)
Figure 66. China Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. Japan Contraceptives Sales Growth Rate (2016-2021) (MT)
Figure 68. Japan Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. South Korea Contraceptives Sales Growth Rate (2016-2021) (MT)
Figure 70. South Korea Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. India Contraceptives Sales Growth Rate (2016-2021) (MT)
Figure 72. India Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Australia Contraceptives Sales Growth Rate (2016-2021) (MT)
Figure 74. Australia Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Taiwan Contraceptives Sales Growth Rate (2016-2021) (MT)
Figure 76. Taiwan Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Indonesia Contraceptives Sales Growth Rate (2016-2021) (MT)
Figure 78. Indonesia Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Thailand Contraceptives Sales Growth Rate (2016-2021) (MT)
Figure 80. Thailand Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Malaysia Contraceptives Sales Growth Rate (2016-2021) (MT)
Figure 82. Malaysia Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Philippines Contraceptives Sales Growth Rate (2016-2021) (MT)
Figure 84. Philippines Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Vietnam Contraceptives Sales Growth Rate (2016-2021) (MT)
Figure 86. Vietnam Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Latin America Contraceptives Sales Growth Rate 2016-2021 (MT)
Figure 88. Latin America Contraceptives Revenue Growth Rate 2016-2021 (US$ Million)
Figure 89. Latin America Contraceptives Sales Market Share by Country in 2020
Figure 90. Latin America Contraceptives Revenue Market Share by Country in 2020
Figure 91. Mexico Contraceptives Sales Growth Rate (2016-2021) (MT)
Figure 92. Mexico Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Brazil Contraceptives Sales Growth Rate (2016-2021) (MT)
Figure 94. Brazil Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 95. Argentina Contraceptives Sales Growth Rate (2016-2021) (MT)
Figure 96. Argentina Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 97. Middle East and Africa Contraceptives Sales Growth Rate 2016-2021 (MT)
Figure 98. Middle East and Africa Contraceptives Revenue Growth Rate 2016-2021 (US$ Million)
Figure 99. Middle East and Africa Contraceptives Sales Market Share by Country in 2020
Figure 100. Middle East and Africa Contraceptives Revenue Market Share by Country in 2020
Figure 101. Turkey Contraceptives Sales Growth Rate (2016-2021) (MT)
Figure 102. Turkey Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 103. Saudi Arabia Contraceptives Sales Growth Rate (2016-2021) (MT)
Figure 104. Saudi Arabia Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 105. U.A.E Contraceptives Sales Growth Rate (2016-2021) (MT)
Figure 106. U.A.E Contraceptives Revenue
  • Global Drugs for Vulvovaginal Candidiasis Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 119
    According to our LPI (LP Information) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at US$ 798.8 million in 2023. With growing demand in downstream market, the Drugs for Vulvovaginal Candidiasis is forecast to a readjusted size of US$ 890 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Drugs for Vulvovaginal Candidiasis market. Drugs for Vulvovaginal Candidiasis are expected t......
  • Global Bacterial Vaginosis Drug Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132
    According to our LPI (LP Information) latest study, the global Bacterial Vaginosis Drug market size was valued at US$ 896.6 million in 2023. With growing demand in downstream market, the Bacterial Vaginosis Drug is forecast to a readjusted size of US$ 1111.1 million by 2030 with a CAGR of 3.1% during review period. The research report highlights the growth potential of the global Bacterial Vaginosis Drug market. Bacterial Vaginosis Drug are expected to show stable growth in the future ma......
  • Global Contraceptives Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 141
    According to our LPI (LP Information) latest study, the global Contraceptives market size was valued at US$ 1870.3 million in 2023. With growing demand in downstream market, the Contraceptives is forecast to a readjusted size of US$ 2237.4 million by 2030 with a CAGR of 2.6% during review period. The research report highlights the growth potential of the global Contraceptives market. Contraceptives are expected to show stable growth in the future market. However, product differentiation,......
  • Global Drugs for Vulvovaginal Candidiasis Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 108
    According to our (Global Info Research) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at USD 840.2 million in 2023 and is forecast to a readjusted size of USD 928.4 million by 2030 with a CAGR of 1.4% during review period. The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cu......
  • Global Menopausal Hot Flashes Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 99
    Market Overview of Global Menopausal Hot Flashes market: According to our latest research, the global Menopausal Hot Flashes market looks promising in the next 5 years. As of 2022, the global Menopausal Hot Flashes market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Hot flashes during menopause are symptoms of menopause. They refer to the warmth that occurs during the transition period of ......
  • Global Bacterial Vaginosis Drug Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 139
    Report Overview: This report studies the Bacterial Vaginosis Drug market, Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria. This report includes metronidazole, clindamycin drug and other drugs. The Global Bacterial Vaginosis Drug Market Size was estimated at USD 916.50 million in 2022 and is projected to reach USD 1127.18 million by 202......
  • Global Drugs for Vulvovaginal Candidiasis Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 122
    Report Overview: The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cure rates in excess of 80%. The only oral azole agent approved for this indication by the US Food and Drug Administration (FDA) is fluconazole, which also achieves a high cure rate. Therapeutic concentrations are found in vaginal secretions for a......
  • Global Bacterial Vaginosis Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 108
    Market Overview of Global Bacterial Vaginosis Drug market: According to our latest research, the global Bacterial Vaginosis Drug market looks promising in the next 5 years. As of 2022, the global Bacterial Vaginosis Drug market was estimated at USD 972.77 million, and it's anticipated to reach USD 1215.68 million in 2028, with a CAGR of 3.79% during the forecast years. Bacterial vaginosis (BV), also known as bacterial vaginosis, non-specific vaginitis is a disease that occurs......
  • Global Tocolysis Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 30-Nov-2023        Price: US 3380 Onwards        Pages: 123
    Market Overview of Global Tocolysis Drugs market: According to our latest research, the global Tocolysis Drugs market looks promising in the next 5 years. As of 2022, the global Tocolysis Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Tocolytics are medications used to suppress premature labor. Tocolytic therapy is provided when delivery would result in premature birth, postponi......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs